stockrowKrystal Biotech, Inc. (KRYS) vs Protagonist Therapeutics, Inc. (PTGX)
- Krystal Biotech, Inc. KRYS 300.31 +0.02%
- Protagonist Therapeutics, Inc. PTGX 131.81 −2.55%
Krystal Biotech, Inc. and Protagonist Therapeutics, Inc. are both Biotechnology companies. Krystal Biotech, Inc. and Protagonist Therapeutics, Inc. are of similar size ($8.9B and $8.8B). Krystal Biotech, Inc. trades at the lower P/E: 39.2× against 111×. Protagonist Therapeutics, Inc. grew revenue faster over the last twelve months: 34.8% against 26.0%. Krystal Biotech, Inc. has the higher net margin (47.9% vs 29.4%) and the lower return on invested capital (27.2% vs 61.8%). Across the 19 metrics below, Krystal Biotech, Inc. leads on 15 and Protagonist Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | KRYS | PTGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.27% | 100.00% | 65.16% |
| Operating margin | 48.41% | 20.69% | 0.00% |
| Net margin | 47.91% | 29.40% | 0.00% |
| Free cash flow margin | 65.97% | 46.31% | 0.00% |
| Return on equity | 17.50% | 10.98% | (50.12%) |
| Return on assets | 15.93% | 10.34% | (45.60%) |
| Return on invested capital | 27.15% | 61.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack